X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   ADCOCK INGRAM
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
ADCOCK INGRAM
Jun-14
JUBILANT LIFE SCIENCES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs187403-   
Low Rs65291-   
Sales per share (Unadj.) Rs364.3119.9-  
Earnings per share (Unadj.) Rs6.8-30.2-  
Cash flow per share (Unadj.) Rs24.5-25.0-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.994.1-  
Shares outstanding (eoy) m159.28168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 11.9%   
Avg P/E ratio x18.4-11.5 -160.2%  
P/CF ratio (eoy) x5.1-13.9 -37.1%  
Price / Book Value ratio x0.83.7 20.7%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,06158,557 34.3%   
No. of employees `0006.24.3 144.1%   
Total wages/salary Rs m11,0523,675 300.7%   
Avg. sales/employee Rs Th9,383.04,714.3 199.0%   
Avg. wages/employee Rs Th1,786.9856.1 208.7%   
Avg. net profit/employee Rs Th176.3-1,187.9 -14.8%   
INCOME DATA
Net Sales Rs m58,03420,238 286.7%  
Other income Rs m191142 134.5%   
Total revenues Rs m58,22420,380 285.7%   
Gross profit Rs m5,786-3,507 -165.0%  
Depreciation Rs m2,812873 321.9%   
Interest Rs m3,237548 590.5%   
Profit before tax Rs m-72-4,787 1.5%   
Minority Interest Rs m-286-13 2,143.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696299 232.8%   
Profit after tax Rs m1,090-5,100 -21.4%  
Gross profit margin %10.0-17.3 -57.5%  
Effective tax rate %-965.9-6.2 15,457.7%   
Net profit margin %1.9-25.2 -7.5%  
BALANCE SHEET DATA
Current assets Rs m29,28014,823 197.5%   
Current liabilities Rs m38,9128,340 466.6%   
Net working cap to sales %-16.632.0 -51.8%  
Current ratio x0.81.8 42.3%  
Inventory Days Days84111 76.1%  
Debtors Days Days51124 40.9%  
Net fixed assets Rs m55,7128,640 644.8%   
Share capital Rs m15594 164.4%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,26515,885 165.3%   
Long term debt Rs m17,1695,582 307.6%   
Total assets Rs m88,60630,008 295.3%  
Interest coverage x1.0-7.7 -12.6%   
Debt to equity ratio x0.70.4 186.0%  
Sales to assets ratio x0.70.7 97.1%   
Return on assets %4.9-15.2 -32.2%  
Return on equity %4.2-32.1 -12.9%  
Return on capital %11.6-19.8 -58.4%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,0261,727 464.6%  
From Investments Rs m-1,744-530 328.8%  
From Financial Activity Rs m-4,4475,066 -87.8%  
Net Cashflow Rs m1,8346,263 29.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.56 Rs / ZAR

Compare JUBILANT LIFE SCIENCES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: ALKEM LABORATORIES  TORRENT PHARMA  PFIZER  WOCKHARDT LTD.  CADILA HEALTHCARE  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views On News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 23, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS